Company news: Amgen
The FDA's Oncologic Drug Advisory Committee voted 12-1 against approving Amgen's bone-cancer drug, Xgeva, as a preventative measure for men ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.